Bosentan REMS requirements will change June 27, 2022
On April 29, 2022, the U.S. Food and Drug Administration approved a modification to the Bosentan Risk Evaluation and Mitigation Strategy (REMS) program. Beginning June 27, 2022, system changes for Health care professionals will go into effect. All stakeholders should find and document their enrollment ID or certification ID, username, and password, as well as confirm their email address is correct before June 24. This information is necessary to log into the new Bosentan REMS platform starting June 27. Please visit the Bosentan REMS website for instructions on finding your enrollment ID or certification ID and username. Communications from the Bosentan REMS will come from information@bosentanREMSprogram.org. Please check e-mail spam folders or mark information@bosentanREMSprogram.org as a safe sender. Important chan...